agilon health Q2 net income $18M vs loss; raises FY2026 guidance

agilon health, inc.

Total revenue $1.49B (+7% YoY); net income $18M vs net loss $104M in Q2 2025.
Medical margin $197M vs negative $53M; Adjusted EBITDA $70M vs negative $83M.
Total members 549,000 (down 10% YoY) due to disciplined contracting and market exits.
FY2026 guidance raised: revenue $5,775-$5,860M, medical margin $465-$505M, Adj. EBITDA $75-$95M.
Q3 2026 guidance: revenue $1,445-$1,475M, medical margin $105-$115M, Adj. EBITDA ($5)-$5M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.